Report Ocean introduces a fresh report examining the ‘Global Non-alcoholic Steatohepatitis (NASH) Diagnostics Market’, encompassing its size, share, growth, industry trends, and forecast up to 2032. This comprehensive analysis delves into various industry components and growth patterns that offer valuable insights for anticipating the market’s future trajectory.
Obtain a comprehensive report on the Global Non-alcoholic Steatohepatitis (NASH) Diagnostics Market, which includes a full table of contents, over 120 tables and figures, and charts. The report provides precise information on the market before and after the COVID-19 outbreak, segmented by region.
Request to Download Free Sample Copy of ‘Global Non-alcoholic Steatohepatitis (NASH) Diagnostics Market’ Report: –https://reportocean.us/sample-request/report_id/IND109
The global epidemic of type 2 diabetes and rising obesity are leading to the growing prevalence of non-alcoholic steatohepatitis (NASH), especially in developed nations. According to the NASH Education Program, NASH affects around 12% of the world’s adult population. More than 80% of patients with NASH are obese, 44% have type 2 diabetes, and 72% have abnormal blood lipids (triglycerides and cholesterol). The increasing prevalence of these ailments is expected to drive the demand for NASH diagnostics over the 2018-2023 period.
Programs and initiatives to increase awareness are anticipated to bolster market growth over the forecast period. In 2016, The NASH Education Program was established with the objective of spreading awareness among medical practitioners, patients identified with NASH, and individuals at high risk of developing it. On the other hand, rising investments for the development of accurate, reliable, and readily available diagnostic tests for NASH is expected to drive the market over the forecast period.
Diagnostic techniques segment insights:
Liver biopsy is one of the broadly accepted diagnostic techniques for NASH detection since it provides accurate results. Liver biopsy is preferred by medical practitioners owing to its ability to determine the degree of steatosis and inflammation accurately. However, the invasive liver biopsy procedure has several disadvantages, such as pain, bleeding, and the possibility of injuring other organs. Thus, the adoption of non-invasive imaging techniques and biomarkers is anticipated to increase significantly. As a result, the market size of the liver biopsy technique is expected to grow at a slower rate than biomarkers, in developed regions like North America and Europe.
Regional insights:
North America held the largest share of the NASH diagnostics market. The growing prevalence of obesity and type 2 diabetes is leading to an increasing number of patients suffering from NASH in the United States (U.S.) and Canada. NASH has been reported to be the second-most common cause for liver transplantations in the U.S. By 2020, it is expected to surpass hepatitis C as the leading cause for liver transplants. Asia-Pacific is expected to be the fastest growing market owing to increasing awareness among patients and improving healthcare infrastructure. However, the high cost of NASH diagnosis through liver biopsy is restraining the growth of the market in developing regions like Latin America and Asia-Pacific.
Companies covered:
1. GENFIT SA
2. Echosens
3. SuperSonic Imagine
4. BioPredictive
5. One Way Liver, S.L. (OWL)
6. VLVbio AB
7. Quest Diagnostics Incorporated
8. Prometheus Laboratories Inc.
9. Siemens Healthcare GmbH.
10. Exalenz Bioscience Ltd.
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada)
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific)
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa)
Some Questions Answered in the Non-alcoholic Steatohepatitis (NASH) Diagnostics Market Report:
- What is the projected size of the global Non-alcoholic Steatohepatitis (NASH) Diagnostics market in 2032, and what growth rate is expected?
- What are the primary drivers of growth in the global Non-alcoholic Steatohepatitis (NASH) Diagnostics industry?
- What are the major market trends that are affecting the expansion of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
- What obstacles must be overcome in order to achieve sustained growth in the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
- What opportunities and threats do vendors in the global Non-alcoholic Steatohepatitis (NASH) Diagnostics market face?
- What are the raw materials and manufacturing equipment used in the production of Non-alcoholic Steatohepatitis (NASH) Diagnostics, and what is the manufacturing process?
- What are the different types and applications of Non-alcoholic Steatohepatitis (NASH) Diagnostics, and what is the market share of each type and application?
- What factors, such as trends, challenges, and risk factors, are currently shaping the growth of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
- What factors are driving the growth of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market in the top regions worldwide?
- Who are the major players in the global Non-alcoholic Steatohepatitis (NASH) Diagnostics market, and what strategies are they employing to succeed?
- What industrial trends, drivers, and challenges are influencing the expansion of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
- What are the main findings of a five forces analysis of the global Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.